American Journal of Medical Genetics Part B: Neuropsychiatric Genetics最新文献

筛选
英文 中文
UBE3A Dosage Imbalance as a Molecular Framework Linking Angelman Syndrome and Dup15q-Associated Autism Phenotypes UBE3A剂量失衡是Angelman综合征和dup15q相关自闭症表型之间的分子框架
IF 1.4 3区 医学
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Pub Date : 2026-11-02 Epub Date: 2026-07-16 DOI: 10.1002/ajmg.b.70025
Ruslan Kurmashev
{"title":"UBE3A Dosage Imbalance as a Molecular Framework Linking Angelman Syndrome and Dup15q-Associated Autism Phenotypes","authors":"Ruslan Kurmashev","doi":"10.1002/ajmg.b.70025","DOIUrl":"10.1002/ajmg.b.70025","url":null,"abstract":"<p>UBE3A is a dosage-sensitive HECT E3 ubiquitin ligase whose neuronal expression is shaped by genomic imprinting at the 15q11.2-q13 locus. Opposite directions of UBE3A dosage imbalance contribute to distinct neurodevelopmental phenotypes: loss of maternal UBE3A underlies Angelman syndrome, whereas maternally derived 15q11.2-q13 copy-number gains, including interstitial duplications and isodicentric inv. dup(15)/idic(15) rearrangements, contribute to Dup15q-associated syndromic autism phenotypes. This review synthesizes evidence across molecular architecture, isoform biology, neuronal imprinting, synaptic regulation, circuit excitability, and therapeutic development. The central argument is that UBE3A should not be interpreted as a general explanation for autism, but as a mechanistically informative model for a defined subset of neurodevelopmental disorders in which parent-of-origin effects and copy-number state are central. In Angelman syndrome, UBE3A loss disrupts proteostasis, synaptic plasticity, inhibitory circuit function, and neuronal excitability through distributed rather than single-pathway mechanisms. In the maternally derived Dup15q spectrum, increased UBE3A dosage is strongly implicated in neuronal and synaptic abnormalities, although interval-wide dosage effects also contribute. Therapeutically, the direction of dosage change creates opposite translational requirements: restoration or paternal reactivation in Angelman syndrome versus dosage normalization in Dup15q-associated overdosage states. A dosage-directionality framework may therefore clarify how UBE3A biology connects molecular mechanism, developmental timing, and precision therapeutic design.</p>","PeriodicalId":7673,"journal":{"name":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics","volume":"201 8","pages":"475-482"},"PeriodicalIF":1.4,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajmg.b.70025","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148475547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Skin Picking in Prader–Willi Syndrome: Independent of Sensory Processing, Maladaptive Behaviors, and Genetic Subtype Prader-Willi综合征的皮肤采摘:独立的感觉加工,适应不良行为和遗传亚型。
IF 1.4 3区 医学
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Pub Date : 2026-11-02 Epub Date: 2026-07-29 DOI: 10.1002/ajmg.b.70027
Yuji Oto, Hiroyuki Ogata, Erina Nakane, Sohei Saima, Takeshi Inoue, Nobuyuki Murakami, Toshiro Nagai, Satomi Koyama, Hiroshi Ihara, Tomozumi Takatani
{"title":"Skin Picking in Prader–Willi Syndrome: Independent of Sensory Processing, Maladaptive Behaviors, and Genetic Subtype","authors":"Yuji Oto,&nbsp;Hiroyuki Ogata,&nbsp;Erina Nakane,&nbsp;Sohei Saima,&nbsp;Takeshi Inoue,&nbsp;Nobuyuki Murakami,&nbsp;Toshiro Nagai,&nbsp;Satomi Koyama,&nbsp;Hiroshi Ihara,&nbsp;Tomozumi Takatani","doi":"10.1002/ajmg.b.70027","DOIUrl":"10.1002/ajmg.b.70027","url":null,"abstract":"<div>\u0000 \u0000 <p>Skin picking, a prevalent and clinically significant issue, can lead to chronic wounds, infections, scarring, and a substantial burden on patients with Prader–Willi syndrome (PWS) and caregivers. However, the psychological and behavioral correlates of skin picking in PWS are poorly understood, and its relationship with sensory processing abnormalities and maladaptive behaviors has not been systematically examined. We conducted a retrospective cross-sectional study involving individuals with genetically confirmed PWS. Skin picking severity was assessed using the Skin Picking Scale (SPS). Sensory processing characteristics and maladaptive behaviors were evaluated using the Japanese versions of the Short Sensory Profile (SSP) and the Aberrant Behavior Checklist (ABC), respectively. Sixty-five individuals with PWS were included. SPS scores showed substantial individual variability. Skin picking severity was not significantly associated with the SSP or ABC subscale scores (all <i>p</i> &gt; 0.05). There were no significant differences in the total SPS scores across the genetic subtypes. Overall, skin picking severity in individuals with PWS was not associated with sensory processing abnormalities, broad maladaptive behaviors, cognitive functioning, or genetic subtypes. These findings suggest that skin picking in patients with PWS may reflect a relatively independent neurobehavioral feature and could inform future research regarding its underlying mechanisms.</p>\u0000 </div>","PeriodicalId":7673,"journal":{"name":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics","volume":"201 8","pages":"483-488"},"PeriodicalIF":1.4,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148623878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic Variation in ADHD-Related Risk Genes in an Indigenous Population of the Amazon 亚马逊地区土著人群adhd相关风险基因的遗传变异
IF 1.4 3区 医学
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Pub Date : 2026-11-02 Epub Date: 2026-08-11 DOI: 10.1002/ajmg.b.70028
Hirlesson Paixão de Matos, Natasha Monte, Kaio Evandro Cardoso Aguiar, Rita de Cássia Calderaro, Aline Pasquini Santos, Juliana Carla Gomes Rodrigues, André Maurício Ribeiro-Dos-Santos, Sandro José De Souza, Ândrea Ribeiro-Dos-Santos, João Farias Guerreiro, Sidney Emanuel Batista Dos Santos, Ney Pereira Carneiro Dos Santos
{"title":"Genetic Variation in ADHD-Related Risk Genes in an Indigenous Population of the Amazon","authors":"Hirlesson Paixão de Matos,&nbsp;Natasha Monte,&nbsp;Kaio Evandro Cardoso Aguiar,&nbsp;Rita de Cássia Calderaro,&nbsp;Aline Pasquini Santos,&nbsp;Juliana Carla Gomes Rodrigues,&nbsp;André Maurício Ribeiro-Dos-Santos,&nbsp;Sandro José De Souza,&nbsp;Ândrea Ribeiro-Dos-Santos,&nbsp;João Farias Guerreiro,&nbsp;Sidney Emanuel Batista Dos Santos,&nbsp;Ney Pereira Carneiro Dos Santos","doi":"10.1002/ajmg.b.70028","DOIUrl":"10.1002/ajmg.b.70028","url":null,"abstract":"<p>Attention-Deficit/Hyperactivity Disorder (ADHD) is a highly heritable neurodevelopmental disorder; however, its genetic architecture remains poorly explored in Indigenous populations. This study aimed to analyze and characterize genetic variation in 11 genes (<i>ADGRL3, CDH8, DCC, DUSP6, FOXP1, FOXP2, MEF2C, PCDH7, SEMA6D, SORCS3,</i> and <i>ST3GAL3</i>) previously implicated in ADHD, in an indigenous sample, comparing them with reference populations from the 1000 Genomes Project. Exome data from 64 individuals representing 12 Indigenous groups from the Brazilian Amazon were analyzed. Among the identified, 99 met the inclusion criteria. Four previously unreported variants in the developed reference datasets were identified in <i>ADGRL3</i>, <i>DCC</i>, and <i>FOXP2</i>. Significant differences in allele frequencies were observed for 56 variants compared with continental populations. Multidimensional scaling analysis indicated genetic differentiation of the Indigenous group in relation to other populations. This study highlights the distinct genetic profile of Amazonian Indigenous populations, likely shaped by demographic and evolutionary processes such as genetic drift and founder effects. The identification of exclusive variants and marked allele frequency differences reinforces the importance of including historically underrepresented populations in genomic studies related to ADHD and neurodevelopment, contributing to a broader understanding of human genetic diversity.</p>","PeriodicalId":7673,"journal":{"name":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics","volume":"201 8","pages":"489-497"},"PeriodicalIF":1.4,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajmg.b.70028","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148714975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mental Health Stigma in Psychiatric Genetics: Insights and Recommendations From the ISPG Member Survey on Stigma 精神病学遗传学中的心理健康病耻感:来自ISPG成员对病耻感调查的见解和建议。
IF 1.4 3区 医学
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Pub Date : 2026-11-02 Epub Date: 2026-08-12 DOI: 10.1002/ajmg.b.70029
Anaïs B. Thijssen, Elleke Tissink, Reeteka Sud, Mandy Johnstone, Richard Josiassen, Andrea Lahti, Laura Huckins, Ariana Page, Stigma Reduction Interest Group of the ISPG, Jordan W. Smoller, Jehannine Austin, Janneke Zinkstok, Sarah E. Medland, Rada Veeneman, Anna R. Docherty
{"title":"Mental Health Stigma in Psychiatric Genetics: Insights and Recommendations From the ISPG Member Survey on Stigma","authors":"Anaïs B. Thijssen,&nbsp;Elleke Tissink,&nbsp;Reeteka Sud,&nbsp;Mandy Johnstone,&nbsp;Richard Josiassen,&nbsp;Andrea Lahti,&nbsp;Laura Huckins,&nbsp;Ariana Page,&nbsp;Stigma Reduction Interest Group of the ISPG,&nbsp;Jordan W. Smoller,&nbsp;Jehannine Austin,&nbsp;Janneke Zinkstok,&nbsp;Sarah E. Medland,&nbsp;Rada Veeneman,&nbsp;Anna R. Docherty","doi":"10.1002/ajmg.b.70029","DOIUrl":"10.1002/ajmg.b.70029","url":null,"abstract":"<p>Little is known about how stigma is perceived within psychiatric genetics, a field increasingly central to public discussions about heredity, neurodiversity, and psychiatric risk. Understanding how stigma is perceived and experienced by psychiatric geneticists is important for guiding responsible communication and future stigma-reduction efforts. The International Society of Psychiatric Genetics (ISPG) Stigma Reduction Special Interest Group surveyed members' experiences and perceptions of mental health-related stigma (122 responses; response rate = 11.3%). Two-thirds believed that psychiatric genetics research reduces stigma, and there was a general consensus that researchers should consider stigma-related impacts when communicating research findings. Almost half of respondents perceived public stigma toward the field, and one-third reported avoiding certain research projects due to stigma-related concerns. Among respondents with a mental health diagnosis, 51% described selective disclosure at work shaped by fears of judgment or career impact. Respondents reported the persistence of stigmatizing attitudes within workplaces, despite reporting perceptions of meaningful cultural improvements in recent years. This first empirical assessment of stigma among psychiatric genetics professionals provides several key action points for the field: (1) developing stigma-sensitive research communication guidelines, (2) explicitly include individuals with lived experience, (3) reconsidering mentoring and hiring practices, and (4) evaluating organizational stigma-reducing efforts.</p>","PeriodicalId":7673,"journal":{"name":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics","volume":"201 8","pages":"498-508"},"PeriodicalIF":1.4,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajmg.b.70029","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148715129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trace Elements Genetics: A Potential Role in Treatment-Resistant Major Psychoses and Related Traits? 微量元素遗传学:在治疗难治性重大精神病及其相关性状中的潜在作用?
IF 1.4 3区 医学
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Pub Date : 2026-11-02 Epub Date: 2026-08-19 DOI: 10.1002/ajmg.b.70030
Chiara Fabbri, Alessandro Serretti, Marco Menchetti, Benedetta Vai, Francesco Benedetti, Lidia Fortaner-Uyà, Concetta Crisafulli
{"title":"Trace Elements Genetics: A Potential Role in Treatment-Resistant Major Psychoses and Related Traits?","authors":"Chiara Fabbri,&nbsp;Alessandro Serretti,&nbsp;Marco Menchetti,&nbsp;Benedetta Vai,&nbsp;Francesco Benedetti,&nbsp;Lidia Fortaner-Uyà,&nbsp;Concetta Crisafulli","doi":"10.1002/ajmg.b.70030","DOIUrl":"10.1002/ajmg.b.70030","url":null,"abstract":"<p>Trace elements are pivotal to key biological processes, with possible effects on psychopathology. We investigated the hypothesis of shared genetic factors between trace elements levels, treatment resistance and related traits. We used genome-wide summary statistics for trace elements blood concentration, treatment-resistant depression (TRD), treatment-resistant schizophrenia (TRS), and related traits, including anhedonia, neurovegetative symptoms, suicidal ideation, and cognition. Cross-trait genetic correlations (<i>r</i>\u0000 <sub>g</sub>) were estimated with High-Definition Likelihood with Bonferroni correction (<i>α</i> = 0.0031). Significant <i>r</i>\u0000 <sub>g</sub> were tested by two-sample Mendelian randomization (MR) and polygenic scores (PGSs) in UK Biobank. We found an inverse <i>r</i>\u0000 <sub>g</sub> between zinc and TRD (<i>r</i>\u0000 <sub>g</sub> = −0.20, SE = 0.07, <i>p</i> = 4.52 × 10<sup>−3</sup>), and a consistent non-significant trend for TRS (<i>p</i> = 0.06). Copper correlated positively with appetite/weight gain (<i>r</i>\u0000 <sub>g</sub> = 0.11, SE = 0.036, <i>p</i> = 0.0026). MR provided no evidence of causal effects of zinc levels on TRD or copper levels on appetite/weight gain, possibly reflecting weak instruments. The PGS of zinc was not associated with TRD, nor the PGS of copper with appetite/weight gain, in UK Biobank (<i>n</i> = 15,927 and <i>n</i> = 35,849, respectively). Our results suggested genetic correlations involving zinc and TRD, copper and neurovegetative symptomatology, without support for a causal model or predictive effect of the respective PGSs. This may suggest limited power, residual confounding, or alternative shared genetic architectures.</p>","PeriodicalId":7673,"journal":{"name":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics","volume":"201 8","pages":"509-519"},"PeriodicalIF":1.4,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajmg.b.70030","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148804455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
“It's Not Deterministic and It Will Never Be Deterministic”: A Qualitative Study on Stakeholder Perspectives of Polygenic Risk Score Testing for Post-Traumatic Stress Disorder “它不是决定性的,也永远不会是决定性的”:创伤后应激障碍多基因风险评分测试利益相关者视角的定性研究。
IF 1.4 3区 医学
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Pub Date : 2026-09-03 Epub Date: 2026-04-15 DOI: 10.1002/ajmg.b.70018
Brandy M. Fox
{"title":"“It's Not Deterministic and It Will Never Be Deterministic”: A Qualitative Study on Stakeholder Perspectives of Polygenic Risk Score Testing for Post-Traumatic Stress Disorder","authors":"Brandy M. Fox","doi":"10.1002/ajmg.b.70018","DOIUrl":"10.1002/ajmg.b.70018","url":null,"abstract":"<p>Post-traumatic stress disorder (PTSD) causes significant mental and physical distress, yet only a small subset of individuals exposed to trauma develop the disorder. Scientists and clinicians are still unable to predict who will get the disorder or how it will manifest. Genetic factors contribute to PTSD risk, but integrating genetic findings into clinical practice has been challenging. Military veterans are especially impacted by PTSD and have different treatment outcomes when compared to civilians. Thus, genetic findings related to PTSD may be particularly valuable to this population. This qualitative study explored expectations and concerns regarding polygenic risk score (PRS) testing for PTSD risk among three stakeholder groups: military veterans diagnosed with PTSD, clinicians who treat veterans with PTSD, and researchers specializing in PTSD genetics. Through semi-structured interviews, I developed three themes that each convey a unique aspect of how research participants conceptualize some potential avenues for pre-empting and living with PTSD, should PRS become widely available: (1) Controlling what you can; (2) The complexity of PTSD; (3) Potential risks for an increased emphasis on the genetic component of PTSD. Understanding stakeholder perspectives is crucial for tailoring education efforts, anticipating ethical challenges, and facilitating the responsible, equitable integration of PRS into clinical settings in the future.</p>","PeriodicalId":7673,"journal":{"name":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics","volume":"201 7","pages":"441-450"},"PeriodicalIF":1.4,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajmg.b.70018","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147694692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic Risk and High Burden of Depression and Suicide in the Maya-Mestizo Population of Yucatán, México 遗传风险和高负担的抑郁和自杀在玛雅-梅斯蒂索人Yucatán, m录影带。
IF 1.4 3区 医学
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Pub Date : 2026-09-03 Epub Date: 2026-04-12 DOI: 10.1002/ajmg.b.70017
Marta Menjivar, Erandi Bravo, Margarita Rivera-Balancan, Barbara Itzel Pena Espinoza
{"title":"Genetic Risk and High Burden of Depression and Suicide in the Maya-Mestizo Population of Yucatán, México","authors":"Marta Menjivar,&nbsp;Erandi Bravo,&nbsp;Margarita Rivera-Balancan,&nbsp;Barbara Itzel Pena Espinoza","doi":"10.1002/ajmg.b.70017","DOIUrl":"10.1002/ajmg.b.70017","url":null,"abstract":"<p>Major depression and suicide are critical public health concerns, particularly in underrepresented populations with unique genetic and sociocultural contexts. The Maya-mestizo population presents the highest suicide rates in the country but remains understudied in psychiatric genetics. This study evaluated the association between three genetic variants, rs7305115 (<i>TPH2</i>), rs6265 (<i>BDNF</i>), and rs2428707 (<i>HTR2C</i>), and the presence of major depression, melancholic subtype, and suicide risk in Maya-mestizo adults. A total of 598 participants were recruited from urban and rural areas. Psychiatric evaluations were performed using the MINI 5.0 (DSM-IV), and functional status was assessed with the Karnofsky scale. Genotyping was performed with TaqMan assays, and ancestry was confirmed with ancestry-informative markers. Analyses included Hardy–Weinberg equilibrium testing and logistic regression models adjusted for sex and included age, body mass index, Karnofsky performance scale score, and sociodemographic variables as covariates. The prevalence of major depression was 38.9%, while suicide risk reached 24.7%. The rs2428707 variant of <i>HTR2C</i> was significantly associated with major depression (OR 2.31, 95% CI 1.03–5.18, <i>p</i> = 0.041). Variants in <i>TPH2</i> and <i>BDNF</i> were associated with the melancholic subtype. No statistically significant associations were found with suicide risk, though overlap with depressive phenotypes suggests shared vulnerability. This first report of psychiatric genetics in the Maya-mestizo population highlights the need for culturally and genetically tailored interventions.</p>","PeriodicalId":7673,"journal":{"name":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics","volume":"201 7","pages":"431-440"},"PeriodicalIF":1.4,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajmg.b.70017","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147680114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interaction of FXTAS Family History and College Degree Attainment Predicts Trajectories of Cognitive and Motor Symptoms in FMR1 Premutation Carrier Women FXTAS家族史与大学学历的相互作用预测了FMR1先兆携带者女性认知和运动症状的轨迹。
IF 1.4 3区 医学
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Pub Date : 2026-09-03 Epub Date: 2026-05-21 DOI: 10.1002/ajmg.b.70022
Jinkuk Hong, Leann Smith DaWalt, Jessica Klusek, Elizabeth M. Berry-Kravis, Marsha Mailick
{"title":"Interaction of FXTAS Family History and College Degree Attainment Predicts Trajectories of Cognitive and Motor Symptoms in FMR1 Premutation Carrier Women","authors":"Jinkuk Hong,&nbsp;Leann Smith DaWalt,&nbsp;Jessica Klusek,&nbsp;Elizabeth M. Berry-Kravis,&nbsp;Marsha Mailick","doi":"10.1002/ajmg.b.70022","DOIUrl":"10.1002/ajmg.b.70022","url":null,"abstract":"<p>The present longitudinal study focuses on <i>FMR1</i> premutation carrier women during midlife and early old age (<i>n</i> = 115). Bringing together the genetic risk factor of a family history of FXTAS and the environmental protective factor of higher education, the goal of the study was to determine how these factors potentially interact to predict self-reported FXTAS-type symptoms in women carrying the <i>FMR1</i> premutation. We investigated age-related changes in symptoms, measured prospectively over a decade. Using an accelerated longitudinal design approach, we estimated trajectories of change extending from early midlife (starting at age 39) into older age (up to age 80) in a community-based cohort. Results indicated that women with the <i>FMR1</i> premutation who have a family history of FXTAS are at greater risk for experiencing symptoms during late midlife and older age than those who do not have such a family history. Consistent with research on other neurodegenerative diseases, this family history risk may be moderated by completing a college education, suggesting that cognitive enrichment during a period of neuroplasticity might provide protection from the neurodegenerative symptoms that are experienced by some women with the premutation as they age.</p>","PeriodicalId":7673,"journal":{"name":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics","volume":"201 7","pages":"451-463"},"PeriodicalIF":1.4,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajmg.b.70022","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147990708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of Genetic Correlations Between Tobacco or Alcohol Use and Neurodegenerative Diseases Using East Asian Genetic Ancestry Genome-Wide Association Study Results 利用东亚遗传祖先全基因组关联研究结果评估烟草或酒精使用与神经退行性疾病之间的遗传相关性
IF 1.4 3区 医学
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Pub Date : 2026-09-03 Epub Date: 2026-05-27 DOI: 10.1002/ajmg.b.70024
Linda Wang, Wiame Belbellaj, Frida Lona-Durazo, Sarah A. Gagliano Taliun
{"title":"Assessment of Genetic Correlations Between Tobacco or Alcohol Use and Neurodegenerative Diseases Using East Asian Genetic Ancestry Genome-Wide Association Study Results","authors":"Linda Wang,&nbsp;Wiame Belbellaj,&nbsp;Frida Lona-Durazo,&nbsp;Sarah A. Gagliano Taliun","doi":"10.1002/ajmg.b.70024","DOIUrl":"10.1002/ajmg.b.70024","url":null,"abstract":"<p>Alzheimer's disease (AD) and Parkinson's disease (PD) are the most prevalent late-onset neurodegenerative diseases worldwide. Both are influenced in part by genetic factors and are currently incurable. Tobacco and alcohol, the two most common substances used among the general adult population, are potential AD/PD risk factors and are also heritable. Although important progress has been made, most existing research on the genetics of AD and PD has been carried out in individuals of European genetic ancestry. Investigations in a broad range of groups are crucial to understand disease mechanisms. Given the current availability of ancestry-specific tobacco and alcohol use as well as AD and PD genome-wide association study summary statistics, we performed global and local genetic correlation analyses using East Asian datasets. Genes within the correlated genetic regions were subsequently used to identify potentially enriched biological pathways between substance use and neurodegenerative diseases. We identified a global genetic correlation between smoking cessation and PD, which we confirmed in complementary European genetic ancestry data. Gene set enrichment analyses highlighted potentially shared genetic mechanisms between breast cancer and AD, which warrants further exploration. This work aims to promote further analyses across genetic ancestry groups.</p>","PeriodicalId":7673,"journal":{"name":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics","volume":"201 7","pages":"464-471"},"PeriodicalIF":1.4,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajmg.b.70024","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148038401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genome-Wide Association Study of Symptom Change Following Cognitive Behavioral Therapy for Common Mental Disorders 常见精神障碍认知行为治疗后症状改变的全基因组关联研究
IF 1.4 3区 医学
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Pub Date : 2026-08-03 Epub Date: 2026-03-09 DOI: 10.1002/ajmg.b.70015
Julia Bäckman, Olly Kravchenko, Matthew Halvorsen, Elles de Schipper, Ekaterina Ivanova, Viktor Kaldo, Nils Hentati Isacsson, Thorstein Olsen Eide, Kira D. Höffler, Manuel Mattheisen, Bjarne Hansen, Gerd Kvale, Kristen Hagen, Jan Haavik, David Mataix-Cols, James J. Crowley, John Wallert, Christian Rück, Nordic OCD and Related Disorders Consortium (NORDiC)
{"title":"Genome-Wide Association Study of Symptom Change Following Cognitive Behavioral Therapy for Common Mental Disorders","authors":"Julia Bäckman,&nbsp;Olly Kravchenko,&nbsp;Matthew Halvorsen,&nbsp;Elles de Schipper,&nbsp;Ekaterina Ivanova,&nbsp;Viktor Kaldo,&nbsp;Nils Hentati Isacsson,&nbsp;Thorstein Olsen Eide,&nbsp;Kira D. Höffler,&nbsp;Manuel Mattheisen,&nbsp;Bjarne Hansen,&nbsp;Gerd Kvale,&nbsp;Kristen Hagen,&nbsp;Jan Haavik,&nbsp;David Mataix-Cols,&nbsp;James J. Crowley,&nbsp;John Wallert,&nbsp;Christian Rück,&nbsp;Nordic OCD and Related Disorders Consortium (NORDiC)","doi":"10.1002/ajmg.b.70015","DOIUrl":"10.1002/ajmg.b.70015","url":null,"abstract":"<p>Cognitive behavioral therapy (CBT) is a well-established, evidence-based treatment for common mental disorders such as depression, anxiety disorders, and obsessive-compulsive disorder (OCD). However, treatment outcomes vary widely, and a substantial proportion of patients do not achieve sufficient improvement. Robust predictors of individual differences in symptom change are currently lacking. Genetic differences have been suggested to play a role, but existing evidence is inconclusive. This study investigated the extent to which common genetic variants—single nucleotide polymorphisms (SNPs)—contribute to variability in symptom change. The sample was derived from the MULTI-PSYCH and NORDiC cohorts, comprising 3113 adults and children treated with CBT for depression, panic disorder, social anxiety disorder, or OCD. We performed a genome-wide association study (GWAS) of symptom change following CBT and estimated the proportion of variance attributed to SNPs. Secondary analyses included GWAS and SNP-based heritability estimation of additional clinically relevant outcomes: pre- and post-treatment symptom severity and remission status. No variants reached genome-wide significance. We estimated SNP-based heritability of symptom change at <span></span><math>\u0000 <semantics>\u0000 <mrow>\u0000 <msubsup>\u0000 <mi>h</mi>\u0000 <mi>SNP</mi>\u0000 <mn>2</mn>\u0000 </msubsup>\u0000 </mrow>\u0000 </semantics></math> = 0.221 (SE = 0.123). These results suggest that common genetic variation may contribute modestly to treatment outcomes. Much larger samples would be required to obtain more precise estimates and to detect genome-wide significant loci.</p>","PeriodicalId":7673,"journal":{"name":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics","volume":"201 6","pages":"396-405"},"PeriodicalIF":1.4,"publicationDate":"2026-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajmg.b.70015","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147392115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书